The Ajanta Pharma stock jumped 13.38 per cent to hit a high of Rs 2,531.95 on BSE. A few target prices on the stock are in ...

Ajanta Pharma shares surged by 13.70% to reach a new high of ₹2,540 apiece following a strong performance in Q4 and full ...

The Mumbai-based pharma major's revenue came in at Rs 1,054.08 crore, up 20 percent from Rs 881.84 crore a year back.

Ajanta Pharma said its revenue from operations grew 20 per cent YoY to Rs 1,054 crore compared with Rs 882 crore in the ...

The company anticipates the fastest growth to come from its dermatology portfolio, followed by ophthalmology and cardiology.

Ajanta Pharma on Thursday said its consolidated net profit increased 66 per cent to Rs 203 crore in the March quarter, aided ...

Ajanta Pharma on Thursday announced a Rs 285 crore buyback of up to 10.28 lakh shares through a tender offer at a price of Rs ...

Indian market witnessed profit-taking on Friday tracking muted global cues. The S&P BSE Sensex plunged more than 700 points ...

Friday's gains come after the company's board approved the buyback of its shares and reported its March quarter earnings. This is the fourth buyback of equity shares for Ajanta Pharma since 2020.

Rajesh Palviya has recommended to buy, hold, and accumulate Hero MotoCorp Ltd, Crompton Greaves Consumer Electricals Ltd, and ...

Mumbai Based, Ajanta Pharma on Thursday reported a consolidated net profit of Rs 202.72 crore for the January-March quarter, ...

Ajanta Pharma recorded a 66 per cent on year spike in consolidated net profit to ₹202.72 crore for the January-March period.